Related Experiment Video
Updated: Jan 11, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Association Between Relapse and Long-Term Kidney Outcomes in IgA Nephropathy
Xue Shen1,2,3,4, Pei Chen1,2,3,4, Miao Hui1,2,3,4,5
1Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Relapse is common in IgA nephropathy (IgAN) after remission, increasing kidney disease progression. Controlling proteinuria below 0.3 g/d at remission significantly reduces relapse risk.
Area of Science:
- Nephrology
- Immunology
- Clinical Research
Background:
- IgA nephropathy (IgAN) relapse post-remission is under-researched.
- Understanding relapse incidence and risk factors is crucial for patient outcomes.
Purpose of the Study:
- Investigate IgAN relapse incidence in a prospective cohort.
- Assess the association between relapse and adverse kidney outcomes.
- Identify clinicopathological predictors of IgAN relapse.
Main Methods:
- Prospective cohort study of 1,069 IgAN patients in remission.
- Cox regression and LASSO Cox regression analyzed relapse predictors.
- Outcomes included end-stage kidney disease or 50% eGFR decline.
Main Results:
- 33% of patients experienced relapse.
- Relapse significantly increased kidney endpoint events and accelerated eGFR decline.
- Corticosteroid-induced remission was linked to higher early relapse; proteinuria <0.3 g/d at remission improved relapse-free rates.
Conclusions:
- IgAN relapse is prevalent and associated with worse kidney outcomes.
- Clinicopathological factors and medications predict relapse.
- Strict proteinuria control (<0.3 g/d) at remission is key to reducing relapse.
More Related Videos
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations

